These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32726179)

  • 1. Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
    Marino A; De Souza M; Giani T; Cimaz R
    Expert Opin Pharmacother; 2020 Dec; 21(17):2161-2168. PubMed ID: 32726179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic agents in juvenile spondyloarthropathies.
    Katsicas MM; Russo R
    Pediatr Rheumatol Online J; 2016 Mar; 14(1):17. PubMed ID: 26968522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile Spondyloarthritis: focus on uveitis.
    Marino A; Weiss PF; Brandon TG; Lerman MA
    Pediatr Rheumatol Online J; 2020 Sep; 18(1):70. PubMed ID: 32912296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of enthesitis-related arthritis and juvenile-onset spondyloarthritis: a cross-sectional study in a pediatric and adult clinic.
    Lanças SHS; Furlan MZB; Fernandes TAP; Drumond SGL; Magalhães CS
    Adv Rheumatol; 2024 May; 64(1):39. PubMed ID: 38720369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre.
    Goirand M; Breton S; Chevallier F; Duong NP; Uettwiller F; Melki I; Mouy R; Wouters C; Bader-Meunier B; Job-Deslandre C; Quartier P
    Pediatr Rheumatol Online J; 2018 Apr; 16(1):21. PubMed ID: 29609643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis.
    Weiss PF; Fuhlbrigge RC; von Scheven E; Lovell DJ; Colbert RA; Brunner HI;
    Arthritis Care Res (Hoboken); 2022 Jul; 74(7):1058-1064. PubMed ID: 33278336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Juvenile Spondyloarthritis.
    Srinivasalu H; Treemarcki EB; Redmond C
    Curr Rheumatol Rep; 2021 Jul; 23(9):70. PubMed ID: 34255209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.
    Hügle B; Horneff G
    Expert Opin Pharmacother; 2016; 17(5):703-14. PubMed ID: 26678914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile spondyloarthritis.
    Gmuca S; Weiss PF
    Curr Opin Rheumatol; 2015 Jul; 27(4):364-72. PubMed ID: 26002028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Unmet Needs in Spondyloarthritis.
    Poddubnyy D; Sieper J
    Curr Rheumatol Rep; 2019 Jul; 21(9):43. PubMed ID: 31302784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of current practices in the management of anti-TNF failure in juvenile spondyloarthritis.
    Srinivasalu H; Oliver M; Stoll ML; Weiss PF; Colbert RA;
    Clin Exp Rheumatol; 2022 Jul; 40(7):1442-1446. PubMed ID: 35485412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial.
    Weiss PF; Sears CE; Brandon TG; Forrest CB; Neu E; Kohlheim M; Leal J; Xiao R; Lovell D
    Trials; 2023 Feb; 24(1):100. PubMed ID: 36755328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short-term follow-up of enthesitis and arthritis in the active phase of juvenile onset spondyloarthropathies.
    Burgos-Vargas R; Pacheco-Tena C; Vázquez-Mellado J
    Clin Exp Rheumatol; 2002; 20(5):727-31. PubMed ID: 12412210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of non-systemic juvenile idiopathic arthritis.
    Shenoi S; Horneff G; Aggarwal A; Ravelli A
    Nat Rev Rheumatol; 2024 Mar; 20(3):170-181. PubMed ID: 38321298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of classification criteria for juvenile spondyloarthropathies.
    Adrovic A; Sezen M; Barut K; Sahin S; Acikel C; Demirkaya E; Kasapcopur O
    Rheumatol Int; 2017 Dec; 37(12):2013-2018. PubMed ID: 29018906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Variants and Therapeutic Response to Anti-TNF-α Agents in Juvenile Idiopathic Arthritis: An Updated Systematic Review and Meta-analysis.
    Pregnolato F; Chighizola CB; Giani T; Costi S; Marino A; Cimaz R
    J Clin Rheumatol; 2022 Oct; 28(7):374-378. PubMed ID: 35777854
    [No Abstract]   [Full Text] [Related]  

  • 18. Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options.
    Pagnini I; Bertini F; Cimaz R
    Paediatr Drugs; 2016 Apr; 18(2):101-8. PubMed ID: 26939782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of classification criteria for juvenile-onset spondyloarthropathies.
    Kasapçopur O; Demirli N; Ozdoğan H; Apelyan M; Calişkan S; Sever L; Arisoy N
    Rheumatol Int; 2005 Aug; 25(6):414-8. PubMed ID: 15034750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
    Tarkiainen M; Tynjälä P; Vähäsalo P; Kröger L; Aalto K; Lahdenne P
    Pediatr Rheumatol Online J; 2019 Dec; 17(1):80. PubMed ID: 31842940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.